Proteinuric Kidney Disease
5 clinical trials · Condition
◉ Watch Proteinuric Kidney Disease
| Record | Firm | Date |
|---|---|---|
| Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease (NCT05312879) | Vertex Pharmaceuticals Incorporated | 2022-03-30 |
| Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease (NCT01129557) | Columbia University | 2009-09-01 |
Track Proteinuric Kidney Disease automatically
Every clearance here is in the API, with alerts when new ones post.